
    
      By enrolling patients with unresectable Urinary Bladder Neoplasms adapted to enrolled
      criteria, this study will document for the first time the safety and the short and long term
      efficacy of percutaneous IRE for unresectable Urinary Bladder Neoplasms.
    
  